Prostate cancer is a prominent global health concern, posing a substantial threat to men's well-being and longevity.
N-7methylguanosine (m7G) modification orchestrated by a complex involving METTL1 and WDR4, has garnered attention as a post-transcriptional modification with implications in numerous tumor types.
Nevertheless, there is a paucity of research addressing potential pivotal roles of METTL1 and WDR4 in driving prostate cancer progression.
